197 related articles for article (PubMed ID: 15972875)
1. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction.
Chua D; Lo C; Babor EM
N Engl J Med; 2005 Jun; 352(25):2647-8; author reply 2647-8. PubMed ID: 15972875
[No Abstract] [Full Text] [Related]
2. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
[TBL] [Abstract][Full Text] [Related]
3. [Optimal platelet inhibition therapy in unstable angina pectoris and after coronary interventions].
Niessner A; Niessner H; Huber K
Herz; 2001 Apr; 26 Suppl 1():36-41. PubMed ID: 11349625
[TBL] [Abstract][Full Text] [Related]
4. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1: Adding clopidogrel to standard treatment for acute myocardial infarction.
Rotheray K
Emerg Med J; 2010 Mar; 27(3):242-3. PubMed ID: 20304905
[No Abstract] [Full Text] [Related]
5. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
[TBL] [Abstract][Full Text] [Related]
6. [Non ST elevation acute coronary syndrome. Some characteristics of coagulation and von Willebrand factor during short term use of ticlopidine or clopidogrel].
Averkov OV; Slavina NN; Gratsianskiĭ NA
Kardiologiia; 2003; 43(10):50-9. PubMed ID: 14593356
[TBL] [Abstract][Full Text] [Related]
7. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.
Mehta SR;
J Invasive Cardiol; 2002 Dec; 14 Suppl E():27E-34E; quiz 35E. PubMed ID: 12668860
[TBL] [Abstract][Full Text] [Related]
8. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
Collins R; Peto R; Baigent C; Sleight P
N Engl J Med; 1997 Mar; 336(12):847-60. PubMed ID: 9062095
[No Abstract] [Full Text] [Related]
9. Patency, perfusion, performance--the desirable triplets of combination thrombolytic therapy.
Wilcox R
Eur Heart J; 2000 Sep; 21(18):1495-7. PubMed ID: 10973761
[No Abstract] [Full Text] [Related]
10. [Antithrombotic treatment protocols in interventional cardiology].
Barragan P; Teuma X; Botosezzy I; Bouvier JL; Comet B; Commeau P; Macaluso G; Roquebert PO
Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1267-73. PubMed ID: 11794968
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.
Otterstad JE; Brosstad F
Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241
[No Abstract] [Full Text] [Related]
12. Unfractionated heparin-clopidogrel combination in ST-elevation myocardial infarction not receiving reperfusion therapy.
Bugiardini R; Dorobantu M; Vasiljevic Z; Kedev S; Knežević B; Miličić D; Calmac L; Trninic D; Daullxhiu I; Cenko E; Ricci B; Puddu PE; Manfrini O; Koller A; Badimon L;
Atherosclerosis; 2015 Jul; 241(1):151-6. PubMed ID: 25988359
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E;
J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290
[TBL] [Abstract][Full Text] [Related]
14. Acute coronary syndromes: clearing up controversies in clopidogrel use.
Cardiovasc J S Afr; 2006; 17(4):213-4. PubMed ID: 17001429
[No Abstract] [Full Text] [Related]
15. [Antithrombotic therapy during percutaneous coronary interventions].
Verheugt FW; Dieker H; Aengevaeren WR
Ned Tijdschr Geneeskd; 2005 Apr; 149(17):912-6. PubMed ID: 15884403
[TBL] [Abstract][Full Text] [Related]
16. Concurrent antiplatelet and fibrinolytic therapy.
Lange RA; Hillis LD
N Engl J Med; 2005 Mar; 352(12):1248-50. PubMed ID: 15758001
[No Abstract] [Full Text] [Related]
17. Clopidogrel--a myocardial infarction CURE?
Bradley C
Intensive Crit Care Nurs; 2001 Dec; 17(6):364-6. PubMed ID: 11853013
[TBL] [Abstract][Full Text] [Related]
18. Facts and controversies of aspirin and clopidogrel therapy.
Faxon DP; Freedman JE
Am Heart J; 2009 Mar; 157(3):412-22. PubMed ID: 19249409
[TBL] [Abstract][Full Text] [Related]
19. Comment: mortality benefit of no-load clopidogrel in COMMIT: not a surprise.
Serebruany VL
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):99-100. PubMed ID: 16703225
[No Abstract] [Full Text] [Related]
20. Antithrombotic therapy for the prevention of reinfarction after reperfusion therapy: the price of success.
Gulati R; Gersh BJ
Rev Esp Cardiol; 2009 May; 62(5):474-8. PubMed ID: 19406060
[No Abstract] [Full Text] [Related]
[Next] [New Search]
